arctosmedical.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Home | |
| Description | ARCTOS medical acquired by ARCTOS medical acquired by |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 217.26.63.20 |
| Location | Switzerland |
Related Websites
| Site | Rank |
More to Explore
arctosmedical.com Valuation
|
US$1,124
Last updated: 2022-07-17 11:24:39
arctosmedical.com has Semrush global rank of 0. arctosmedical.com has an estimated worth of US$ 1,124, based on its estimated Ads revenue. arctosmedical.com receives approximately 129 unique visitors each day. Its web server is located in Switzerland, with IP address 217.26.63.20. According to SiteAdvisor, arctosmedical.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,124 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$31 |
| Yearly Ads Revenue | US$373 |
| Daily Unique Visitors | 8 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| arctosmedical.com. | A | 300 | IP: 217.26.63.20 |
| arctosmedical.com. | AAAA | 300 | IPV6: 2a00:d70:0:a::400 |
| arctosmedical.com. | NS | 3600 | NS Record: ns2.hostpoint.ch. |
| arctosmedical.com. | NS | 3600 | NS Record: ns.hostpoint.ch. |
| arctosmedical.com. | NS | 3600 | NS Record: ns3.hostpoint.ch. |
| arctosmedical.com. | MX | 300 | MX Record: 0 arctosmedical-com.mail.protection.outlook.com. |
| arctosmedical.com. | TXT | 3600 | TXT Record: MS=ms95550087 |
| arctosmedical.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2022-07-17 11:24:39
| Home ARCTOS medical acquired by Novartis media release Basel, September 21, 2021 - Arctos Medical a Swiss start-up developing optogenetic therapies for treating blindness, is acquired by Novartis "We are thrilled that Novartis recognizes the potential value and differentiated profile of Arctos’ unique optogenetics technology," said Kostas Kaloulis, CEO of Arctos and venture partner at +ND Capital. "As a global ophthalmology leader, Novartis is ideally positioned to rapidly advance our program into the clinic. We look forward to progressing the technology to deliver transformative therapies for underserved patients." read more Imprint Privacy Policy Cookie |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: Hostpoint Redirect Service Location: https://www.arctosmedical.com Connection: close HTTP/1.1 200 OK Date: Tue, 02 Nov 2021 16:29:43 GMT Content-Type: text/html Connection: keep-alive Vary: Accept-Encoding X-RateLimit-Limit: 8000 X-RateLimit-Remaining: 7999 X-RateLimit-Reset: 0 Content-Security-Policy: default-src * data: blob: 'self' 'unsafe-inline' 'unsafe-eval'; frame-ancestors 'self' *.jimdo.com jimdo.com; worker-src blob: Vary: Accept-Language, Origin, Cookie Content-Language: en Server: nginx |
arctosmedical.com Whois Information
Domain Name: ARCTOSMEDICAL.COM Registry Domain ID: 2295046030_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.ascio.com Registrar URL: http://www.ascio.com Updated Date: 2021-08-09T07:06:09Z Creation Date: 2018-08-08T07:15:12Z Registry Expiry Date: 2022-08-08T07:15:12Z Registrar: Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA Registrar IANA ID: 106 Registrar Abuse Contact Email: abuse@ascio.com Registrar Abuse Contact Phone: +1.4165350123 Domain Status: ok https://icann.org/epp#ok Name Server: NS.HOSTPOINT.CH Name Server: NS2.HOSTPOINT.CH Name Server: NS3.HOSTPOINT.CH DNSSEC: unsigned >>> Last update of whois database: 2021-09-22T08:30:19Z <<< |